CellaVision Balance Sheet Health
Financial Health criteria checks 5/6
CellaVision has a total shareholder equity of SEK758.8M and total debt of SEK56.1M, which brings its debt-to-equity ratio to 7.4%. Its total assets and total liabilities are SEK974.1M and SEK215.4M respectively. CellaVision's EBIT is SEK180.8M making its interest coverage ratio 80. It has cash and short-term investments of SEK167.0M.
Key information
7.4%
Debt to equity ratio
kr56.09m
Debt
| Interest coverage ratio | 80x |
| Cash | kr166.98m |
| Equity | kr758.76m |
| Total liabilities | kr215.35m |
| Total assets | kr974.12m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: C26's short term assets (SEK392.5M) exceed its short term liabilities (SEK122.0M).
Long Term Liabilities: C26's short term assets (SEK392.5M) exceed its long term liabilities (SEK93.3M).
Debt to Equity History and Analysis
Debt Level: C26 has more cash than its total debt.
Reducing Debt: C26's debt to equity ratio has increased from 0% to 7.4% over the past 5 years.
Debt Coverage: C26's debt is well covered by operating cash flow (444.3%).
Interest Coverage: C26's interest payments on its debt are well covered by EBIT (80x coverage).